|Bid||17.56 x 100|
|Ask||17.57 x 100|
|Day's Range||17.22 - 18.01|
|52 Week Range||16.81 - 53.96|
|PE Ratio (TTM)||224.23|
|Dividend & Yield||1.10 (6.44%)|
|1y Target Est||N/A|
If a company makes money by copying the inventions of others, is it entitled to skim a thick layer of cream off the top? That is the question on the lips of investors in generic drugmakers, after a torrid ...
Citigroup cut its rating for the struggling generic drug maker to 'neutral'.
JERUSALEM/LONDON/FRANKFURT, Aug 16 (Reuters) - Teva Pharmaceutical Industries is looking to team up with other drugmakers to fund some of its development pipeline as it struggles with debts and expiring patents. "We are looking for partners ... a series of partners.